EBA
RMD icon

Eagle Bay Advisors’s ResMed RMD Stock Holding History

Eagle Bay Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4
Closed -$915 – 772
2024
Q4 		$915 Sell
4
-6
-60% -$1.45K ﹤0.01% 942
2024
Q3 		$2.44K Hold
10
– – ﹤0.01% 1183
2024
Q2 		$1.91K Hold
10
– – ﹤0.01% 892
2024
Q1 		$1.98K Hold
10
– – ﹤0.01% 880
2023
Q4 		$1.72K Sell
10
-7
-41% -$1.08K ﹤0.01% 757
2023
Q3 		$2.51K Hold
17
– – ﹤0.01% 739
2023
Q2 		$3.71K Sell
17
-4
-19% -$892 ﹤0.01% 707
2023
Q1 		$4.6K Sell
21
-9
-30% -$1.95K ﹤0.01% 678
2022
Q4 		$6.24K Buy
30
+7
+30% +$1.54K ﹤0.01% 652
2022
Q3 		$5K Buy
23
+3
+15% +$683 ﹤0.01% 680
2022
Q2 		$4.19K Buy
+20
New +$4.26K ﹤0.01% 748
2022
Q1 		– Sell
-29
Closed -$8K – 827
2021
Q4 		$8K Sell
29
-29
-50% -$7.53K 0.01% 727
2021
Q3 		$14K Buy
58
+19
+49% +$5.2K 0.01% 685
2021
Q2 		$10K Buy
+39
New +$8.2K 0.01% 677

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Eagle Bay Advisors's RMD Position: Q1 2025 in Review

Eagle Bay Advisors sold out of ResMed (RMD) in Q1 2025, closing a stake of 4 shares — an estimated $915 sold.

Eagle Bay Advisors first reported a position in RMD in Q2 2021 and held it in 14 quarters. The position peaked at $14K in Q3 2021. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Eagle Bay Advisors reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 4 ResMed shares in Q1 2025, an estimated $915.
  • Eagle Bay Advisors first reported a position in ResMed in Q2 2021 and held it in 14 quarters.
  • Eagle Bay Advisors's ResMed position peaked at $14K in Q3 2021.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.